GAMBARDELLA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 11.510
AS - Asia 7.516
EU - Europa 3.434
SA - Sud America 1.922
AF - Africa 165
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 17
Totale 24.603
Nazione #
US - Stati Uniti d'America 11.131
SG - Singapore 3.571
CN - Cina 1.657
BR - Brasile 1.517
IT - Italia 1.396
VN - Vietnam 805
IN - India 751
SE - Svezia 510
GB - Regno Unito 414
DE - Germania 303
CA - Canada 262
HK - Hong Kong 224
AR - Argentina 170
FI - Finlandia 124
NL - Olanda 109
EE - Estonia 108
ID - Indonesia 92
RU - Federazione Russa 82
BD - Bangladesh 78
MX - Messico 76
ZA - Sudafrica 73
EC - Ecuador 67
RO - Romania 61
IQ - Iraq 60
FR - Francia 54
UA - Ucraina 46
PL - Polonia 45
CO - Colombia 43
JP - Giappone 40
PK - Pakistan 33
VE - Venezuela 33
ES - Italia 31
TR - Turchia 29
AU - Australia 28
CL - Cile 28
PY - Paraguay 27
AT - Austria 23
MA - Marocco 23
PE - Perù 22
SA - Arabia Saudita 19
CZ - Repubblica Ceca 18
EG - Egitto 18
IR - Iran 17
UZ - Uzbekistan 15
IE - Irlanda 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
KR - Corea 12
UY - Uruguay 12
LT - Lituania 11
GR - Grecia 10
JO - Giordania 10
KE - Kenya 10
MY - Malesia 10
NP - Nepal 10
JM - Giamaica 9
EU - Europa 8
KZ - Kazakistan 8
PS - Palestinian Territory 8
TN - Tunisia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
IL - Israele 7
PT - Portogallo 7
TH - Thailandia 7
AL - Albania 6
AO - Angola 6
BE - Belgio 6
CI - Costa d'Avorio 6
DZ - Algeria 6
LB - Libano 6
MD - Moldavia 6
NZ - Nuova Zelanda 6
LV - Lettonia 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
DK - Danimarca 4
ET - Etiopia 4
NG - Nigeria 4
OM - Oman 4
SV - El Salvador 4
CR - Costa Rica 3
GT - Guatemala 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
MK - Macedonia 3
MT - Malta 3
NI - Nicaragua 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CG - Congo 2
GE - Georgia 2
HU - Ungheria 2
KH - Cambogia 2
LU - Lussemburgo 2
Totale 24.568
Città #
San Jose 2.034
Chandler 1.249
Singapore 1.119
Ashburn 1.025
Dallas 999
Santa Clara 642
Bengaluru 564
Hefei 550
Milan 489
Princeton 459
Lawrence 456
Ho Chi Minh City 307
London 307
Chicago 305
Wilmington 273
Hong Kong 216
Munich 209
Beijing 196
Hanoi 180
Ottawa 160
Des Moines 145
São Paulo 138
Boardman 128
Los Angeles 89
Turku 79
Catanzaro 70
The Dalles 68
New York 62
Shanghai 59
Rome 55
Chennai 49
Rio de Janeiro 45
Council Bluffs 44
Guangzhou 44
Helsinki 42
Da Nang 41
Columbus 40
Brooklyn 36
Pune 36
San Francisco 36
Warsaw 35
Orem 34
Amsterdam 32
Boston 32
Johannesburg 32
Curitiba 31
Haiphong 31
Naples 29
Norwalk 29
Redwood City 29
Belo Horizonte 28
Horia 27
Shenzhen 27
Tokyo 27
Porto Alegre 24
Montreal 23
Quito 23
Thái Bình 23
Aversa 22
Brasília 22
San Nicola Manfredi 22
Stockholm 22
Toronto 22
Mexico City 21
Redmond 21
Biên Hòa 20
Buffalo 20
Florence 20
Buenos Aires 19
Charlotte 19
Atlanta 18
Secaucus 18
Timisoara 18
Fortaleza 17
Guayaquil 17
Jakarta 17
Phoenix 17
Seattle 17
Campinas 16
Guarulhos 16
Salvador 16
Augusta 14
Baghdad 14
Dhaka 14
Genoa 14
Hải Dương 14
New Delhi 14
Tashkent 14
Bari 13
Can Tho 13
Cape Town 13
Falls Church 13
Lima 13
Olomouc 13
Boydton 12
Catania 12
Cetraro 12
Frankfurt am Main 12
Asunción 11
Goiânia 11
Totale 14.244
Nome #
Genetics of reflex seizures and epilepsies in humans and animals 158
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 147
Levetiracetam vs Lamotrigine as First-Line Antiseizure Medication in Female Patients With Idiopathic Generalized Epilepsy 140
Rating Scale for Psychogenic Non-epileptic Seizures: Scale Development and Clinimetric Testing 121
A brainstem hypermetabolism in a patient with essential palatal tremor: A simultaneous 18F-FDG-PET/3 T-MRI study 103
PRECLINICAL MARKERS OF NEUROPATHIC DAMAGE IN TYPE 1 DIABETES MELLITUS 98
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy 96
A new SLC20A2 mutation identified in southern Italy family with primary familial brain calcification. 93
A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chomosome 1 93
3-T magnetic resonance imaging simultaneous automated multimodal approach improves detection of ambiguous visual hippocampal sclerosis. 93
Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study 92
A Functional Genetic Variation of the 5-HTR2A Receptor Affects Age at Onset in Patients with Temporal Lobe Epilepsy 90
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 89
A software pipeline for pre-processing and mining EEG signals: Application in neurology 88
C19orf12 gene mutations in patients with neurodegeneration with brain iron accumulation 88
A novel exon 1 mutation in a patient with atypical lafora progressive myoclonus epilepsy seen as childhood-onset cognitive deficit 86
Rasmussen's Encephalitis and Related Conditions. The Causes of Epilepsy Common and Uncommon Causes in Adults and Children 85
A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1 85
Chlorpromazine versus sleep deprivation in activation of EEG in adult-onset partial epilepsy. 84
Asymmetry of Permutation Entropy in Early Creutzfeldt-Jakob Disease: A Clue to a Specific Pathological Process? 84
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 84
A hypofibrinolytic state in overweight patients with cerebral venous thrombosis and isolated intracranial hypertension 82
A. Spinal muscular atrophy due to an isolated deletion of Exon 8 of telomeric survival motor neuron gene 81
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 81
Neocortical thinning in “benign” mesial temporal lobe epilepsy 79
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 78
Glucose transporter-1 deficiency syndrome with extreme phenotypic variability in a five-generation family carrying a novel SLC2A1 variant 76
A Multilayer Network-Based Method for Brain Connectivity Analysis from EEG Data 76
Resting-State EEG Classification for PNES Diagnosis 74
Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study 74
A genome-wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine. 73
Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study 71
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 71
A puzzling case without solution: isolated late-onset epileptic seizure 71
Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene 71
Incidental evidence of hypointensity in brain grey nuclei on routine MR imaging: when to suspect a neurodegenerative disorder? 71
Age at onset predicts good seizure outcome in sporadic non-lesional and mesial temporal sclerosis based temporal lobe epilepsy 70
A new Italian instrument for the assessment of irritability in patients with epilepsy. 70
A Loss-of-Function HCN4 Mutation Associated With Familial Benign Myoclonic Epilepsy in Infancy Causes Increased Neuronal Excitability 70
Accidents at work among people with epilepsy. Results of a European prospective cohort study 70
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72 70
Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study 70
A novel de novo HCN1 loss-of-function mutation in genetic generalized epilepsy causing increased neuronal excitability 70
White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study 69
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 68
Advanced morphological neuroimaging study in lateral temporal lobe epilepsy: A multicentric study 68
Perampanel as first add-on choice on the treatment of mesial temporal lobe epilepsy: an observational real-life study 68
Mild non-lesional temporal lobe epilepsy. A common, unrecognized disorder with onset in adulthood 67
A novel ICA-based hardware system for reconfigurable and portable BCI 66
Long-term outcome of mild mesial temporal lobe epilepsy 66
Phenotypic Variability in Novel Doublecortin Gene Variants Associated with Subcortical Band Heterotopia 65
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables 65
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era 65
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 64
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame? 64
Association study between four polymorphisms in the HFE, TF and TFR genes and Parkinson's disease in Southern Italy 64
A novel mutation in the Notch3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings 64
Circulating microrna: The potential novel diagnostic biomarkers to predict drug resistance in temporal lobe epilepsy, a pilot study 64
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies 63
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. 63
Epilepsy in “Sunflower syndrome”: electroclinical features, therapeutic response, and long-term follow-up 63
Idiopathic generalized epilepsy in a family with SCN4A-related myotonia 63
Climate change and hyponatremia-related hospital admissions in people with focal epilepsy exposed to carbamazepine or its derivatives 62
Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features. 62
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 62
Deep learning representation from electroencephalography of early-stage creutzfeldt-jakob disease and features for differentiation from rapidly progressive dementia 62
Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network 61
Blocking out the real diagnosis 61
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 61
Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients 60
A clinical spectrum of the myoclonic manifestations associated with typical absences in childhood absence epilepsy. A video-polygraphic study 60
Integrity of the corpus callosum in patients with benign temporal lobe epilepsy 60
Automatic detection of obstructive sleep apnea syndrome based on snore signals 60
Antiepileptic Drug Teratogenicity and De Novo Genetic Variation Load 60
Operative Strategies for Patients with Cortical Dysplastic Lesions and Intractable Epilepsy 60
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 60
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine 60
Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy 60
The mystery of unexplained traumatic sudden falls. A clinical case that adds a new feasible cause 59
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 59
The parkin gene is not involved in late-onset Parkinson’s disease 59
Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. 59
Deep Learning Representation from Electroencephalography of Early-Stage Creutzfeldt-Jakob Disease and Features for Differentiation from Rapidly Progressive Dementia. 59
Advances in genetic testing and optimization of clinical management in children and adults with epilepsy 58
Genetics heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern 58
The ENIGMA-Epilepsy working group: Mapping disease from large data sets 58
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 57
National survey on the prevalence of single-gene aetiologies for genetic developmental and epileptic encephalopathies in Italy 57
A large family with pure autosomal dominant hereditary spastic paraplegia from southern Italy mapping to chromosome 14q11.2-q24.3 57
Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments 57
Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy 57
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 57
A familial t(4;8) translocation segregates with epilepsy and migraine with aura 57
Development and Validation of Machine-Learning Models to Support Clinical Diagnosis for Non-Epileptic Psychogenic Seizures 56
A System for the Analysis of Snore Signals 56
Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures 56
Partial epilepsy with tonic seizures during sleep: Seizure prognosis in 6 patients 56
Two cases of unilateral wasting and weakness of distal upper limb: Similar onset and different diagnosis in young patients 55
Human iPSC Modeling of Genetic Febrile Seizure Reveals Aberrant Molecular and Physiological Features Underlying an Impaired Neuronal Activity 55
Brand-to-Generic Levetiracetam Switching: a four-years prospective observational real-life study 55
Totale 7.183
Categoria #
all - tutte 235.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 235.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 45 11 6
2021/20221.333 22 5 8 359 147 20 25 303 129 117 191 7
2022/20233.587 923 127 79 382 405 337 10 238 569 215 232 70
2023/20241.623 335 248 155 103 98 386 58 38 13 32 46 111
2024/20255.680 749 395 268 222 330 717 177 215 733 389 495 990
2025/202612.063 617 1.370 1.619 2.254 1.196 451 1.580 750 1.582 644 0 0
Totale 25.057